AQU-005

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAQU-005
Drug Alias NameNM-AQU-005NMAQU-005AQU-005
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase 9 inhibitorsMatrix metalloproteinase-2 inhibitors
TargetsMatrix metalloproteinase 9Matrix metalloproteinase-2
Therapy Area/IndicationsNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAquilus Pharmaceuticals
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A